Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005
The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004
Predictors of Stroke in Middle-Aged Patients with Non-Insulin-Dependent Diabetes
Stroke 27:63-68, Lehto,S.,et al, 1996
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Deteriorating Ischemic Stroke:Risk Factors and Prognosis
Neurol 40:1865-1869, Davalos,A.,et al, 1990
The Neurologist's Experience with Pheochromocytoma
JAMA 197:100, Thomas,J.E.,et al, 1966
ICU-Acquired Weakness and Recovery from Critical Illness
NEJM 370:1626-1635, Kress, J.P. & Hall, J.B., 2014
Neuroimaging in Patients with Abnormal Blood Glucose Levels
AJNR 35:833-840, Bathla, G.,et al, 2014
Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011
C-Reactive Protein Level Measurement Improves Mortality Prediction When Added to the Spontaneous Intracerebral Hemorrhage Score
Stroke 42:1230-1236, Napoli, M.D.,et al, 2011
Lack of Improvement in Patients with Acute Stroke After Treatment with Thrombolytic Therapy
JAMA 292:1839-1844, Saposnik,G.,et al, 2004
The Effect of Intensive Diabetes Therapy on Development & Progression of Neuropathy
The Diabetes Control & Compl Trial Res Gr, Ann Int Med 122:561-56895., , 1995
Blood Glucose and Stroke
Stroke 19:1049-1053, Helgason,C.M., 1988